Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liang Chen
Institution:
University at Buffalo, State University of New York
Observed institution:
University at Buffalo, State University of New York
ORCID:
0000-0001-5845-2235
Observed ORCID:
0000-0001-5845-2235
OpenAlex ID:
A5123137271
CRISPR-AMRtracker: A novel toolkit to monitor the antimicrobial resistance gene transfer in fecal microbiota
2024
·
Gong Li
, Teng-Fei Long
, et al.
·
Drug Resistance Updates
·
8
PDF
Current progress in antibacterial agents for carbapenem-resistant enterobacterales
2026
·
Wenxin Xu
, Lisha Shang
, et al.
·
Frontiers in Pharmacology
·
7
PDF
Genetic basis of cefiderocol resistance in Acinetobacter baumannii : insights from functional genomics and clinical isolates
2026
·
Kevin J. Rome
, José R. Mediavilla
, et al.
·
Microbiology Spectrum
·
3
Bacteriophage Therapy Against Klebsiella Pneumoniae
2026
·
Weijia Ding
, Yicheng Wen
, et al.
·
Microorganisms
·
3
PDF
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant Pseudomonas aeruginosa and clinical implications in the prospective observational Pseudomonas study
2026
·
Lee S. Gottesdiener
, Yixuan Li
, et al.
·
Antimicrobial Agents and Chemotherapy
·
2
Clinical and molecular characterization of NDM-9 and NDM-13 producing multidrug-resistant Escherichia coli strains in China
2026
·
Jia Tao
, Gang Li
, et al.
·
BMC Microbiology
·
2
RpoE-mediated virulence attenuation elicits protective immunity in hypervirulent Klebsiella pneumoniae
2026
·
Yaxuan Zhai
, Qiyuan Jin
, et al.
·
Emerging Microbes & Infections
·
1
Near pan-β-lactam resistance in NDM-producing Escherichia coli with PBP3 insertions is overcome by dual PBP2/PBP3 inhibition
2026
·
Jackson V. Watkins
, Peter A. Smith
, et al.
·
npj Antimicrobials and Resistance
·
1
PDF
Risk factors for in vivo emergence of ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae and the associated resistance mechanisms: a case-control study
2026
·
Chien Chuang
, Szu-Yu Liu
, et al.
·
Microbiology Spectrum
·
1
Escherichia coli ST131 Drives Carbapenem Use for E. coli Bloodstream Infections
2026
·
Natalie A Mackow
, Wanying Shao
, et al.
·
Clinical Infectious Diseases
·
1
Emerging infection and nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae harboring bla NDM-21 in a neonatal intensive care unit
2026
·
Song Hu
, Hua Tan
, et al.
·
Virulence
PDF
In vitro and in vivo antibacterial activity of oral tebipenem in combination with novel β-lactamase inhibitors (avibactam, relebactam, vaborbactam) against KPC-producing Enterobacterales
2026
·
Chunhong Zou
, Jinyi Shen
, et al.
·
European Journal of Clinical Microbiology & Infectious Diseases
First report of a nosocomial outbreak of ST101 Klebsiella pneumoniae carrying bla OXA-48 in Shandong, China
2026
·
Wanxiang Li
, Qizhao Gao
, et al.
·
Microbial Genomics
Diabetes Unmasks the Invasive Potential of Circulating Hypermucoviscous Klebsiella Pneumoniae
2026
·
Claire Wate
, Zajeba Tabashsum
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
14
Citation count:
28
H-index:
3
I10-index:
Year
Topic
Type